Study S001936

Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02654665
Acronym: CGH-LiNASH
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: PHASE3
Masking: NONE
Status: UNKNOWN
Enrollment: 36
Start: 2014-03
Primary completion: 2017-12
Lead sponsor: Changi General Hospital
Conditions: Non-alcoholic Fatty Liver Disease (NAFLD); Weight Loss; Non-alcoholic Steatohepatitis (NASH)
Interventions: BEHAVIORAL:Lifestyle modification; DRUG:Liraglutide
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Improvement in NASH [12 months]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0025648	Randomized trial comparing effects of weight loss by liraglutide with lifestyle modification in non-alcoholic fatty liver disease. Khoo J, Liver international : official journal of the International Association for the Study of the Liver	2019	Randomized trial	PMID 30721572 DOI	cites ClinicalTrials.gov:NCT02654665; registry reference DERIVED:30721572